Results 11 to 20 of about 411,291 (407)

Transradial retrograde percutaneous coronary intervention of chronic total occlusion using a single guiding catheter: a case report [PDF]

Journal of Medical Case Reports
Background With the development of specialized equipment and the retrograde technique, success rates for percutaneous coronary intervention of chronic total occlusions have increased from 60 to 90% in the past 10 years.
Georgi Goranov, Petko Petrov
doaj   +2 more sources

Clopidogrel and Percutaneous Coronary Interventions [PDF]

JAMA, 2003
case fatality rates in inhaled anthrax can approach 100%. Anthrax bacteria, after being inhaled, use three toxins— protective antigen, oedema factor, and lethal factor—to enter, appropriate, and kill alveolar macrophages. Seven copies of protective antigen assemble and facilitate entry of oedema factor and lethal factor into macrophages.
Brian Y L, Wong, Eric A, Cohen
  +12 more sources

In-hospital Outcomes in Patients Undergoing Percutaneous Coronary Intervention in Peri-urban Area Hospital Without Cardiac Surgery Backup

Journal of Lumbini Medical College, 2021
Introduction: In centers without cardiac surgery backup, current guidelines recommend to conduct emergency percutaneous coronary intervention and discourage elective percutaneous coronary intervention.
Manoj Shrestha, Prakash Aryal
doaj   +1 more source

A Placebo-controlled Trial of Percutaneous Coronary Intervention for Stable Angina

New England Journal of Medicine, 2023
Background Percutaneous coronary intervention (PCI) is frequently performed to improve symptoms of stable angina. Whether PCI without background antianginal medication relieves angina beyond placebo remains unknown.
C. Rajkumar, Michael J. Foley, Fiyyaz Ahmed‐Jushuf, A. Nowbar, F. Simader, John R. Davies, Peter O’Kane, Peter Haworth, Helen Routledge, T. Kotecha, R. Gamma, Gerald Clesham, Rupert Williams, Jehangir Din, S. Nijjer, Nick Curzen, Neil Ruparelia, M. Sinha, Jason N Dungu, Sashiananthan Ganesananthan, R. Khamis, Lal Mughal, Tim Kinnaird, R. Petraco, James Spratt, S. Sen, J. Sehmi, David J Collier, A. Sohaib, Thomas R. Keeble, Graham D Cole, James P. Howard, Darrel P Francis, M. Shun-shin, R. Al-Lamee   +34 more
semanticscholar   +1 more source

Percutaneous coronary intervention

Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics, 2018
Cardiac catheterization is a procedure by which information is obtained from the heart by passing fine plastic tubes (occasionally other instruments) either near to or within the heart, to introduce contrast to cardiac structures to understand their anatomy and function better, to measure pressures, and/or to measure oxygen saturations in different ...
Sam Dawkins, Cheerag Shirodaria
  +6 more sources

Fractional flow reserve in assessment of intermediate non-culprit lesions in acute myocardial infarction [PDF]

Journal of Pharmacy & Pharmacognosy Research, 2023
Context: Percutaneous coronary intervention (PCI) of intermediate non-culprit arteries can reduce death or heart attack risk in patients with acute myocardial infarction and multivessel coronary artery disease.
Do Truong Son Chau, Quang Binh Truong, Do Anh Nguyen, Manh Thong Le, Dinh Dat Nguyen, Anh Tien Hoang   +5 more
doaj   +1 more source

Prognostic value of systemic inflammatory response index in patients with acute coronary syndrome undergoing percutaneous coronary intervention

Annals medicus, 2022
Background The systemic inflammatory response index (SIRI) is a novel inflammatory biomarker in many diseases. Objectives The aim of this study was to examine the association between SIRI and adverse events in patients with the acute coronary syndrome ...
K. Han, D. Shi, Lixia Yang, Zhijian Wang, Yue-ping Li, F. Gao, Yuyang Liu, Xiaoteng Ma, Yujie Zhou   +8 more
semanticscholar   +1 more source

Aspirin Versus Clopidogrel for Long-Term Maintenance Monotherapy After Percutaneous Coronary Intervention: The HOST-EXAM Extended Study

Circulation, 2022
Background: Long-term outcomes of antiplatelet monotherapy in patients who receive percutaneous coronary intervention are unknown. The HOST-EXAM (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis–Extended Antiplatelet Monotherapy ...
Jeehoon Kang, Kyung-Woo Park, H. Lee, D. Hwang, Han-Mo Yang, S. Rha, J. Bae, N. Lee, S. Hur, J. Han, E. Shin, B. Koo, Hyo‐Soo Kim   +12 more
semanticscholar   +1 more source

Antiplatelet therapy after percutaneous coronary intervention.

EuroIntervention, 2022
Antiplatelet therapy is key to reducing local thrombotic complications and systemic ischaemic events among patients undergoing percutaneous coronary interventions (PCI), but it is inevitably associated with increased bleeding.
D. Angiolillo, M. Galli, J. Collet, A. Kastrati, M. O’Donoghue   +4 more
semanticscholar   +1 more source

Imaging in Percutaneous Coronary Intervention

Reviews in Cardiovascular Medicine, 2022
Intracoronary imaging (ICI) use during percutaneous coronary intervention (PCI) has been shown to effectively improve cardiovascular outcomes, particularly for high-risk subgroups. However, data from randomized controlled trials are limited and the overall utilization rate of ICI remains variable between different countries and centers.
Mohan Satish, Anastasios Roumeliotis, David Power, Anton Camaj, Johny Nicolas, Daniel Feldman, Davis Jones, Keisuke Yasumura, Frans Beerkens, Saman Suleman, George Dangas   +10 more
openaire   +3 more sources